The invention belongs to the technical field of
multiple sclerosis, and particularly relates to a tolerogen vaccine microneedle patch for
multiple sclerosis, the tolerogen vaccine microneedle patch for
multiple sclerosis comprises methacryloyl
gelatin and
zeolite imidazole skeleton-8 for encapsulating tolerogen polypeptides, the tolerogen polypeptides are encapsulated by using the
large aperture and extremely high specific surface area of ZIF-8 nanoparticles, and the tolerogen vaccine microneedle patch for multiple sclerosis is prepared from the methacryloyl
gelatin and the
zeolite imidazole skeleton-8 for encapsulating the tolerogen polypeptides. According to the preparation method, efficient loading of a polypeptide
drug is achieved, meanwhile, rapid
crystallization of nanoparticles can prevent degradation of polypeptide and is beneficial to tolerating slow release of original polypeptide, the adopted GelMA hydrogel microneedle has enough
mechanical strength, can penetrate through
skin cuticle and form a
diffusion channel beneficial to release of the polypeptide
drug, and controllable slow release of the polypeptide
drug in
skin tissue can be achieved. The GelMA hydrogel microneedle
drug release device can directly penetrate through the
skin cuticle to deliver the polypeptide drug to the corium layer, so that the sustained and
controlled release of the tolerance original polypeptide in the
skin tissue is realized, the first-pass effect of the liver is avoided, and the treatment purpose is realized by inducing
immune tolerance.